Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genscript Biotech (HK:1548)
HKEX:1548
Holding HK:1548?
Track your performance easily
1548 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$7.43 - HK$24.95
Previous CloseHK$12.02
Volume4.21M
Average Volume (3M)14.73M
Market Cap
HK$25.45B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Mar 21, 2025EPS Estimate
-HK$0.08Last Dividend Ex-Date
Jun 18, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares OutstandingN/A
10 Day Avg. Volume6,128,326
30 Day Avg. Volume14,725,710
Standard Deviation0.20
R-Squared0.03
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)9.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$23.00Price Target Upside91.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Genscript Biotech News
PremiumCompany Announcements
Genscript Biotech Awards Shares to Employees
PremiumCompany Announcements
Genscript Biotech’s H1 2024 Financial Surge
PremiumCompany Announcements
Genscript Biotech Reports Mid-Year FinancialsPremiumCompany Announcements
Genscript Biotech Plans Key Mid-Year Meeting
PremiumCompany Announcements
Genscript Biotech Forecasts Revenue Surge and Lower Losses
PremiumCompany Announcements
Genscript Biotech Unveils Subsidiary’s Mid-Year ResultsPremiumCompany Announcements
Genscript Reports Strong CARVYKTI® Sales in Q2
PremiumCompany Announcements
Genscript Biotech Notes Unexplained Stock FluctuationsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.77% Mutual Funds
4.46% Other Institutional Investors
93.77% Public Companies and
Individual Investors
1548 FAQ
What was Genscript Biotech’s price range in the past 12 months?
Genscript Biotech lowest stock price was HK$7.43 and its highest was HK$24.95 in the past 12 months.
What is Genscript Biotech’s market cap?
Currently, no data Available
When is Genscript Biotech’s upcoming earnings report date?
Genscript Biotech’s upcoming earnings report date is Mar 21, 2025 which is in 208 days.
How were Genscript Biotech’s earnings last quarter?
Genscript Biotech released its earnings results on Aug 09, 2024. The company reported -HK$0.647 earnings per share for the quarter, missing the consensus estimate of -HK$0.078 by -HK$0.569.
Is Genscript Biotech overvalued?
According to Wall Street analysts Genscript Biotech’s price is currently Undervalued.
Does Genscript Biotech pay dividends?
Genscript Biotech pays a Notavailable dividend of HK$0.09 which represents an annual dividend yield of N/A. See more information on Genscript Biotech dividends here
What is Genscript Biotech’s EPS estimate?
Genscript Biotech’s EPS estimate is -HK$0.08.
How many shares outstanding does Genscript Biotech have?
Genscript Biotech has 2,128,305,200 shares outstanding.
What happened to Genscript Biotech’s price movement after its last earnings report?
Genscript Biotech reported an EPS of -HK$0.647 in its last earnings report, missing expectations of -HK$0.078. Following the earnings report the stock price went up 2.932%.
Which hedge fund is a major shareholder of Genscript Biotech?
Currently, no hedge funds are holding shares in HK:1548
---
Genscript Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.54%
12-Months-Change
Fundamentals
Return on Equity
-13.78%
Trailing 12-Months
Asset Growth
-1.55%
Trailing 12-Months
Company Description
Genscript Biotech
Genscript Biotech Corp an investment holding company. It is involved in fundamental life sciences research, translational biomedical research, and early-stage pharmaceutical development businesses. The company segments include bio-science services and products, biologics development services, industrial synthetic biology products, and cell therapy. It generates maximum revenue from the bio-science services and products. Geographically, it derives majority revenue from North America and also has a presence in Europe, China, Asia Pacific, Japan, and Other Countries.
---
1548 Stock 12 Month Forecast
Average Price Target
HK$23.00
▲(91.34% Upside)
Technical Analysis
Benitec Biopharma
―
Genetic Technologies
―
Crispr Therapeutics AG
―
Editas Medicine
―
Genscript Biotech
―
Best Analysts Covering 1548
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-32.70%
reiterated a buy rating 6 months ago
Copying Ziyi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -32.70% per trade.
---